Pulsed corticosteroid treatment in MS patients stabilizes disease activity following natalizumab withdrawal prior to switching to fingolimod. Evangelopoulos ME, Koutoulidis V, Andreadou E, Evangelopoulos DS, Kilidireas C Int J Neurosci. 2016 Jan 4:1-6. PMID: 26727713. Abstract CommentRecommendBookmarkWatch